Int J Arrhythm.  2017 Dec;18(4):209-214. 10.18501/arrhythmia.2017.032.

Two Cases of Transhepatic Implantation of Cardiac Implantable Electronic Device: All Roads lead to Rome

Affiliations
  • 1Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea. mhlee@yuhs.ac
  • 2Division of Cardiology, Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea.

Abstract

Lead insertion for cardiac implantable electronic devices requires venous access into the right side of the heart. The access route commonly used is from the axillary vein, through the subclavian vein and the superior vena cava. However, in patients with congenital heart malformations or those with vascular stenosis, and/or those who have undergone previous cardiac surgery, the passage of leads might be difficult, and the implantation procedure would show restricted scope. In such cases, insertion of leads through the hepatic vein is known to be a safe procedure. We report 2 cases of patients with limited vascular access who underwent lead implantation using the transhepatic approach"”1 patient who underwent placement of an implantable cardioverter defibrillator and the other who underwent placement of a permanent pacemaker.

Keyword

Implantable Cardioverter-Defibrillator; Pacemaker; Transhepatic

MeSH Terms

Axillary Vein
Constriction, Pathologic
Defibrillators
Defibrillators, Implantable
Heart
Hepatic Veins
Humans
Subclavian Vein
Thoracic Surgery
Vena Cava, Superior
Full Text Links
  • IJA
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr